Published May 8th, 2015

In 2011, CHAI, supported by the Bill & Melinda Gates Foundation, conducted a study that illustrated the facility-level cost of treatment for HIV/AIDS was significantly lower than previously understood, at US$200 per patient per year in low- and lower middle- income countries. Larger than any study of its kind, the Multi-Country Analysis of Treatment Costs for HIV/AIDS (MATCH) Study was conducted with the governments of Ethiopia, Malawi, Rwanda, South Africa, and Zambia. CHAI has since used this evidence to inform the debate on the affordability and sustainability of universal access to treatment, and support analyses that have made an additional 443,000 patients eligible for treatment.